Publications by authors named "Shuilian Ao"
Purpose: Systemic inflammation biomarkers, derived from routine blood tests, have been demonstrated to be associated with prognosis of patients undergoing peritoneal dialysis (PD). However, studies focusing on the comparisons of their role on predictive efficacy for prognosis of PD patient are limited and results are inconsistent. The purpose of this study was to evaluate the prognostic value of various systemic inflammation biomarkers and to identify the optimal one in PD patients.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates the relationship between the platelet-to-albumin ratio (PAR) and mortality risks in patients undergoing peritoneal dialysis (PD), focusing on cardiovascular disease (CVD) and overall mortality rates.* -
- Conducted with 2825 PD patients over an average follow-up of about 48 months, the research found that higher PAR levels are linked to a significant increase in the risk of both all-cause and CVD-related death.* -
- The results from statistical analyses support the conclusion that PAR can be a useful prognostic marker for predicting mortality outcomes in patients on PD, suggesting that monitoring PAR could improve patient management.*